Bengt R. Danielsson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bengt R. Danielsson has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Helen Elizabeth Ritchie
School of Medical Sciences, Faculty of Medicine and Health University of Sydney Sydney New South Wales Australia
2 shared publications Aaron P Adam
Seattle Children's Research Institute, Seattle, Washington, US
1 shared publicationChristian Danielsson
Department of Patient Safety, Swedish National Board of Health and Welfare, SE-106 30 Stockholm, Sweden
1 shared publicationMargaret P Adam
Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, Washington, USA
1 shared publicationNeil Vargesson
Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
1 shared publication
Latest Publications
- Open Access
- 1 March 2026
- Vol. 118 (3) , e70036
Recurrent Constellations of Embryonic Malformations (RCEM): Teratogenicity Linked to Transient Hypoxia and Hormone Pregnancy Tests Agrees With RCEM and Suggest a Reactive Oxygen Species Pathogenesis.
No consistent genetic etiology has been found for a group of six different conditions in humans with multiple malformations called "recurrent constellations of embryonic malformations" (RCEM). Recent studies indicate hypoxia/reoxygenation and generation Reactive Oxygen Species (ROS) as an underlying mechanism for RCEM with the specific manifestations related to the timing, severity and duration of the ROS exposure. Medical literature was evaluated in relation to a hypoxia/ROS related mechanism for RCEM. Special attention was paid to investigate if the reported spectrum of multiple human malformations for Hormone Pregnancy Tests (HPTs), which have been associated with embryonic hypoxia due abnormal uterine contractions in early pregnancy, agrees with the RCEM spectrum. The pattern of human multiple and single malformations associated with HPTs in 44 case reports with multiple defects, 86% (38/44) were consistent with RCEM spectrum, the most common was VACTERL. There was also a high consistency with regards to increases in single HPT malformations within the RCEM spectrum in a large case report study (> 225 cases) and in more than 25 human epidemiological studies evaluating HPT teratogenicity. The RCEM spectrum is also consistent with reported malformations when the embryo has been exposed to periods of transient embryonic hypoxia/ROS in animal studies and when exposed to drugs associated with embryonic hypoxia/ROS (e.g., cocaine) and in some genetic diseases with malformations (e.g., NAD+ deficiency) when ROS overwhelms the antioxidant defense. This review shows that HPTs are associated with human teratogenicity and ROS to be the proximate teratogen underlying RCEM.
- 1 March 2026
- Vol. 118 (3) , e70036
Open AccessRecurrent Constellations of Embryonic Malformations (RCEM): Teratogenicity Linked to Transient Hypoxia and Hormone Pregnancy Tests Agrees With RCEM and Suggest a Reactive Oxygen Species Pathogenesis.
No consistent genetic etiology has been found for a group of six different conditions in humans with multiple malformations called "recurrent constellations of embryonic malformations" (RCEM). Recent studies indicate hypoxia/reoxygenation and generation Reactive Oxygen Species (ROS) as an underlying mechanism for RCEM with the specific manifestations related to the timing, severity and duration of the ROS exposure. Medical literature was evaluated in relation to a hypoxia/ROS related mechanism for RCEM. Special attention was paid to investigate if the reported spectrum of multiple human malformations for Hormone Pregnancy Tests (HPTs), which have been associated with embryonic hypoxia due abnormal uterine contractions in early pregnancy, agrees with the RCEM spectrum. The pattern of human multiple and single malformations associated with HPTs in 44 case reports with multiple defects, 86% (38/44) were consistent with RCEM spectrum, the most common was VACTERL. There was also a high consistency with regards to increases in single HPT malformations within the RCEM spectrum in a large case report study (> 225 cases) and in more than 25 human epidemiological studies evaluating HPT teratogenicity. The RCEM spectrum is also consistent with reported malformations when the embryo has been exposed to periods of transient embryonic hypoxia/ROS in animal studies and when exposed to drugs associated with embryonic hypoxia/ROS (e.g., cocaine) and in some genetic diseases with malformations (e.g., NAD+ deficiency) when ROS overwhelms the antioxidant defense. This review shows that HPTs are associated with human teratogenicity and ROS to be the proximate teratogen underlying RCEM.
- Open Access
- 14 March 2025
- Published by Wiley in Birth Defects Research
- Vol. 117 (3) , e2462
Review: Hormone Pregnancy Tests Were Teratogenic by the Same Failed Abortion and Hypoxia‐Related Mechanism as Misoprostol
Introduction: Hormone pregnancy tests (HPTs), containing synthetic progesterone and oestrogen, were used to diagnose pregnancy in the 1950s to early 1980s. An existing pregnancy was purported to be unaffected while expulsion of the uterine lining (withdrawal bleed) was supposed to occur if the woman was not pregnant. However, studies in the 1960s–1980s associated HPTs with teratogenicity and some countries banned their use in the early 1970s. Following renewed scientific and political interest, studies were published from 2014–2023.Materials and Methods: This review evaluates whether HPTs fulfil scientific criteria to be teratogenic based on results in old and newer human, animal and mechanistic studies.Results and Discussion: The evaluation shows that HPT teratogenicity is identical to the established human teratogen misoprostol, with limb reductions, neural tube defects and urinary‐renal system defects as the most significant. The evaluation also presents evidence for abnormal uterine contractions and failed abortion (but the embryo survives) and hypoxia/ROS‐related damage (including vascular disruption) in the embryo secondary to compression of uterine/embryonic vessels, as underlying the teratogenicity. Animal studies show human malformations associated with HPTs could be induced by a single period of embryonic hypoxia, and that HPTs have both abortive and teratogenic potential.Conclusion: Altogether, HPTs fulfil criteria to be characterised as a human teratogen.
- 14 March 2025
- Published by Wiley in Birth Defects Research
- Vol. 117 (3) , e2462
Open AccessReview: Hormone Pregnancy Tests Were Teratogenic by the Same Failed Abortion and Hypoxia‐Related Mechanism as Misoprostol
Introduction: Hormone pregnancy tests (HPTs), containing synthetic progesterone and oestrogen, were used to diagnose pregnancy in the 1950s to early 1980s. An existing pregnancy was purported to be unaffected while expulsion of the uterine lining (withdrawal bleed) was supposed to occur if the woman was not pregnant. However, studies in the 1960s–1980s associated HPTs with teratogenicity and some countries banned their use in the early 1970s. Following renewed scientific and political interest, studies were published from 2014–2023.Materials and Methods: This review evaluates whether HPTs fulfil scientific criteria to be teratogenic based on results in old and newer human, animal and mechanistic studies.Results and Discussion: The evaluation shows that HPT teratogenicity is identical to the established human teratogen misoprostol, with limb reductions, neural tube defects and urinary‐renal system defects as the most significant. The evaluation also presents evidence for abnormal uterine contractions and failed abortion (but the embryo survives) and hypoxia/ROS‐related damage (including vascular disruption) in the embryo secondary to compression of uterine/embryonic vessels, as underlying the teratogenicity. Animal studies show human malformations associated with HPTs could be induced by a single period of embryonic hypoxia, and that HPTs have both abortive and teratogenic potential.Conclusion: Altogether, HPTs fulfil criteria to be characterised as a human teratogen.
- Open Access
- 16 October 2023
- Published by Elsevier in Reproductive Toxicology
- Vol. 122, 108488
Teratogenicity and Reactive Oxygen Species after transient embryonic hypoxia: Experimental and clinical evidence with focus on drugs causing failed abortion in humans
- 16 October 2023
- Published by Elsevier in Reproductive Toxicology
- Vol. 122, 108488
Open AccessTeratogenicity and Reactive Oxygen Species after transient embryonic hypoxia: Experimental and clinical evidence with focus on drugs causing failed abortion in humans